FDA Drug recall D-0719-2023

vancomycin added to dextrose 5%, 1.25 g/250 mL* (5 mg/mL), 250 mL per bag, Rx only, Central Admixture Pharmacy Services, Inc., 6580 Snowdri…

FDA Drug
Class II
terminated
Published 2023-05-31

On 2023-05-31 the FDA classified a Class II recall of vancomycin added to dextrose 5%, 1.25 g/250 mL* (5 mg/mL), 250 mL per bag, Rx only, Central Admixture Pharmacy Services, Inc., 6580 Snowdri… by Central Admixture Pharmacy Services, citing lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.

Read the official FDA Drug notice

Agency	FDA Drug
Recall number	D-0719-2023
Classification	Class II
Status	terminated
Initiated	2023-04-28
Published	2023-05-31
Last updated	2026-09-13 11:52 UTC
Company	Central Admixture Pharmacy Services
Distribution	US

Product

vancomycin added to dextrose 5%, 1.25 g/250 mL* (5 mg/mL), 250 mL per bag, Rx only, Central Admixture Pharmacy Services, Inc., 6580 Snowdrift Rd., Ste 100, Allentown, PA 18106, NDC 71285-6073-1.

Reason

Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.

Identifiers

code_info	Lot # 37-883198, 37-883202, 37-883203, 37-883204, Exp 04/30/2023; 37-883799, Exp 05/02/2023; 37-884159, Exp 05/03/2023;… Lot # 37-883198, 37-883202, 37-883203, 37-883204, Exp 04/30/2023; 37-883799, Exp 05/02/2023; 37-884159, Exp 05/03/2023; 37-884888, 37-884892, 37-884899, 37-884901, Exp 05/07/2023; 37-886836, 37-886855, 37-886861, Exp 05/15/2023; 37-887381, Exp 05/16/2023; 37-887664, Exp 05/17/2023; 37-888256, 37-888259, 37-888267, Exp 05/21/2023; 37-888624, 37-888625, Exp 05/22/2023; 37-890038, 37-890041, 37-890042, Exp 05/28/2023; 37-890331, 37-890336, 37-890350, Exp 05/29/2023; 37-891163, Exp 05/31/2023; 37-892008, 37-892012, 37-892015, Exp 06/05/2023; 37-892882, 37-892884, Exp 06/07/2023

code_info

Lot # 37-883198, 37-883202, 37-883203, 37-883204, Exp 04/30/2023; 37-883799, Exp 05/02/2023; 37-884159, Exp 05/03/2023;…

Lot # 37-883198, 37-883202, 37-883203, 37-883204, Exp 04/30/2023; 37-883799, Exp 05/02/2023; 37-884159, Exp 05/03/2023; 37-884888, 37-884892, 37-884899, 37-884901, Exp 05/07/2023; 37-886836, 37-886855, 37-886861, Exp 05/15/2023; 37-887381, Exp 05/16/2023; 37-887664, Exp 05/17/2023; 37-888256, 37-888259, 37-888267, Exp 05/21/2023; 37-888624, 37-888625, Exp 05/22/2023; 37-890038, 37-890041, 37-890042, Exp 05/28/2023; 37-890331, 37-890336, 37-890350, Exp 05/29/2023; 37-891163, Exp 05/31/2023; 37-892008, 37-892012, 37-892015, Exp 06/05/2023; 37-892882, 37-892884, Exp 06/07/2023

Status history

No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:52 UTC. Current status: terminated.

Source

Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0719-2023%22

RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.